Cynthia Rodriguez
Payments from drug & device makers
Across 139 payments — averaging $36.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AstraZeneca$583
- Lilly USA, LLC$509
- Medtronic$437
- Inspire Medical Systems, Inc.$332
- Amgen$302
- plus $2K from 16 others
What the payments were for
- Food & beverage$5,071100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 62 | $1,169 |
| AstraZeneca | 13 | $583 |
| Lilly USA, LLC | 21 | $509 |
| Medtronic | 4 | $437 |
| Inspire Medical Systems, Inc. | 4 | $332 |
| Amgen(2 entities) | 6 | $302 |
| Bayer | 2 | $265 |
| AbbVie | 3 | $227 |
| Dexcom, Inc. | 4 | $219 |
| Astellas Pharma US Inc | 6 | $204 |
| Intuity Medical Inc | 1 | $149 |
| Biomarin Pharmaceutical Inc. | 1 | $134 |
| Averitas Pharma Inc. | 2 | $132 |
| Gilead | 1 | $101 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $81 |
| Genentech USA, Inc. | 1 | $62 |
| Sanofi-aventis U.S. LLC | 2 | $44 |
| Nevro Corp. | 1 | $40 |
| Ironwood Pharmaceuticals, Inc | 1 | $24 |
| Kowa Pharmaceuticals America, Inc. | 1 | $20 |
| Boehringer Ingelheim | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTERSTIM$344
- Kerendia$265
- Inspire$243
- RYBELSUS$237
- EVENITY$150
- Pogo Automatic Blood Glucose Monitoring System$149
- VOXZOGO 1.2mg$134
- ZEPBOUND$125
- MOUNJARO$125
- Veozah$115
- Qutenza$115
- VRAYLAR$115
- DEXCOM G7 GSS (161)$108
- DEXCOM STELO GLUCOSE BIOSENSOR$108
- Epclusa$101
- QULIPTA$100
How this compares
$5,071 in reported general payments places this provider in the 85th percentile of 1,490 medical providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 113 | $142,723 |
| MounjaroTirzepatide | 61 | $70,892 |
| JardianceEmpagliflozin | 27 | $28,977 |
| SynjardyEmpagliflozin/Metformin Hcl | 18 | $28,044 |
| FarxigaDapagliflozin Propanediol | 25 | $27,892 |
| LinzessLinaclotide | 27 | $22,747 |
| MyrbetriqMirabegron | 18 | $20,057 |
| RybelsusSemaglutide | 12 | $19,419 |
| KerendiaFinerenone | 16 | $17,936 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 16 | $15,123 |
| JanumetSitagliptin Phos/Metformin Hcl | 11 | $13,641 |
| Tresiba Flextouch U-100Insulin Degludec | 17 | $10,594 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $9,095 |
| Atorvastatin Calcium | 256 | $2,943 |
| Diclofenac Sodium | 38 | $1,905 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $1,169 | $162,142125 claims |
| Lilly USA, LLCMounjaro | $509 | $70,89261 claims |
| Boehringer IngelheimJardiance, Synjardy | $20 | $57,02145 claims |
| AstraZenecaFarxiga | $583 | $27,89225 claims |
| AbbVieLinzess | $227 | $22,74727 claims |
| Astellas Pharma US IncMyrbetriq | $204 | $20,05718 claims |
| BayerKerendia | $265 | $17,93616 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,490 medical providers in Texas.
Other medical in Alton
- Jose de la CerdaSan Antonio$1.1M
- Mark DavisFort Worth$1M
- Joey Dixon-JulianBoerne$458K
- Terry FaleyeKingwood$243K
- Kimberly PoarchDallas$166K
- Erin DuhaimeDallas$150K
- Courtney AldridgeSan Antonio$129K
- Shakira CabreraSan Antonio$116K
- Danny DeckardDallas$101K
- Janine ShinnDallas$84K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.